Clinical trial
Effect of Sitagliptin on Insulin Resistance and Myocardial Metabolism in Heart Failure
NCT00657280 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Sitagliptin on Insulin Resistance and Myocardial Metabolism in Heart Failure
- Lead sponsor
- Stanford University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- February 29, 2012
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, congestive